CNMD — CONMED Corp

NYSE · Health Care · Health Care Equipment & Supplies · CIK 816956 ·
Last close
$36.06
Market Cap
$1.09B
52W High
$46.55
52W Low
$33.21
ADV30
433,521
Next earnings
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 317,046,000 183,447,000 25,415,000 13,828,000 2,314,942,000 35,030,000 1,297,269,000
Dec 2025 373,198,000 218,285,000 36,624,000 16,739,000 2,325,749,000 40,817,000 1,292,652,000
Sep 2025 337,926,000 166,119,000 11,879,000 2,859,000 2,322,488,000 38,929,000 1,314,225,000
Jun 2025 342,345,000 188,320,000 38,161,000 21,421,000 2,328,458,000 33,935,000 1,325,588,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$142,627,000
Investing CF
$-13,919,000
Financing CF
$-129,975,000
CapEx
$-18,919,000
Dividends Paid
$-18,566,000
Buybacks
$-37,017,000
EPS Diluted TTM
$1.77
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$602,594,000
Inventory
$366,106,000
Receivables
$228,661,000
ST Investments
EBIT TTM
$111,661,000
Pretax Income TTM
$81,800,000
Interest Exp TTM
$29,861,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,370,514,048
EBITDA
$210,655,008
Free Cash Flow
$125,867,624
Enterprise Value
$1,946,803,328
Total Cash
$35,030,000
Total Debt
$860,867,968
Shares Out
30,109,194
Trailing EPS
$1.77
Book Value
$33.76
ROE
5.5%
ROA
3.7%
Div Yield
2.15%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,374,724,000 102,622,000 47,055,000 2,325,749,000 1,292,652,000 170,689,000
Dec 2024 1,307,015,000 200,326,000 132,423,000 2,306,247,000 1,343,566,000 166,968,000
Dec 2023 1,244,744,000 120,603,000 64,459,000 2,300,021,000 1,465,799,000 125,348,000
Dec 2022 1,045,472,000 70,054,000 -80,582,000 2,297,592,000 1,552,047,000 33,365,000

TTM Snapshot

Revenues TTM
$1,145,194,000
NetIncome TTM
$125,919,000
OpCashFlow TTM
$0
Assets (Latest)
$2,306,247,000
Forward EPS
$4.85

Peers — same industry

TickerNameMarket CapLastDaily %
BFLY Butterfly Network, Inc. $1.07B $4.54
AORT ARTIVION, INC. $1.13B $23.19
AVNS AVANOS MEDICAL, INC. $1.16B $24.75
BLFS BIOLIFE SOLUTIONS INC $1.17B $24.03
IART INTEGRA LIFESCIENCES HOLDINGS CORP $1.18B $15.19

News headlines (Yahoo Finance, 1h cache)

Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?
2026-05-25 15:15 · Yahoo
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors
2026-05-20 12:30 · Yahoo
[Latest] Global Orthopedic Soft Tissue Repair Market Size/Share Worth USD 15.38 Billion by 2035 at a 9.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation
2026-05-18 12:30 · Yahoo
Is the Options Market Predicting a Spike in CONMED Stock?
2026-05-14 14:58 · Yahoo
[Latest] Global Flexible Endoscope Market Size/Share Worth USD 22.7 Billion by 2035 at a 6% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate
2026-05-11 17:30 · Yahoo
Does CONMED (CNMD) Refocusing Away From Gastroenterology Clarify Its Long-Term Surgical Growth Story?
2026-05-05 00:18 · Yahoo
Assessing CONMED (CNMD) Valuation After A Mixed Stretch In Recent Share Performance
2026-05-04 14:11 · Yahoo
Is CONMED Corporation (CNMD) A Good Stock To Buy Now?
2026-05-03 18:43 · Yahoo
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms
2026-05-02 04:28 · Yahoo
CONMED Corporation Q1 2026 Earnings Call Summary
2026-04-30 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.